Consistent with these data, the MEK inhibitor U0126 and the NFκB inhibitor BAY 11-7085 downregulated IL6-triggered expression of VEGF, VEGFB, and IGF1 in MM cells (Fig. 3C). This evidence concerns the gene IL6 and Miyoshi myopathy.